CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Sales and marketing expense	$ 46,623	$ 1,027,109	$ 645,218	$ 1,027,109
General and administrative expenses	1,120,250	37,469	2,321,252	73,439
Professional fees	102,484	14,637	132,025	35,237
Related party consulting fees	130,925	41,500	213,425	78,000
Research and development expense	2,859,644	0	5,200,219	0
Total operating expenses	4,259,926	1,120,715	8,512,139	1,213,785
Operating loss	(4,259,926)	(1,120,715)	(8,512,139)	(1,213,785)
Other expenses:
Amortization of debt discount	(1,264,931)	(66,449)	(1,413,959)	(112,410)
Amortization of debt discount, related party	0	(3,044)	0	(5,000)
Financing fees	0		(43,750)	0
Interest expense	(1,625)	(1,139)	(4,014)	(2,196)
Interest expense, related party	0	(46)	0	(76)
Gain on forgiveness of accounts payable	0	(1,956)	0	0
Loss on settlement of debt	(4)	0	(536)	(186,954)
Total other (expense)	(1,266,560)	(72,634)	(1,462,259)	(306,636)
Net loss attributable:
Non-controlling interest	(2,037,053)		(3,214,869)	0
Common stockholders	(3,489,430)		(6,759,529)	0
Net loss	$ (5,526,486)	$ (1,193,349)	$ (9,974,398)	$ (1,520,421)
Net loss per common share - basic and diluted	$ (0.02)	$ (0.01)	$ (0.03)	$ (0.01)
Weighted average number of common shares outstanding - basic and diluted	352,796,331	234,451,953	328,392,903	176,685,459